Abstract
Objective
This study investigated the clinical and functional results of treating congenital pseudarthrosis of the tibia (CPT) using the combined techniques of hamartoma resection, periosteal grafting, circular external fixator application, and intramedullary rodding.
Methods
The clinical and radiological data of 17 patients (mean age at the treatment time: 7.6 months (range: 4.6–9.7 months) with CPT, treated by a single surgeon between 1997 and 2017, were retrospectively analyzed. All data regarding surgical interventions, complications, deformity analysis parameters, limb length discrepancy (LLD), ankle joint range of motion, and residual deformities were reviewed. All the patients were followed up at least two years after the last surgical intervention. The mean follow-up time was 8.5 years (range: 2.2 to 15.7 years).
Results
Union was achieved with the index treatment in 15 of the 17 cases (88.2%). The mean age of the patients at the last follow-up visit was 14.2 years (range: 7.6 to 22.1). The mean LLD was 2.1 cm. Nine patients had radiological ankle valgus at the last follow-up. In the entire series, eight patients did not display any complications, four cases reported minor complications, and five cases were complicated by refractures.
Conclusion
Circular external fixator application combined with periosteal grafting is a superior method of CPT treatment. This method provides a healthy biological healing environment while correcting the mechanical problems. The combination of periosteal and cancellous bone grafts with intramedullary rods and an external fixator addresses issues that complicate obtaining and maintaining a union during the CPT treatment.
Level of Evidence
Level IV, Therapeutic study
Keywords: Congenital pseudarthrosis of the tibia, Success probability, Circular external fixator, Periosteal grafting, Intramedullary rodding
Congenital pseudarthrosis of the tibia (CPT) is a childhood disease causing serious morbidity during its natural course. Treatment of CPT requires solving more than one issue in the affected extremity. The etiology is unknown in the majority of the cases, but neurofibromatosis is present in 40% of the patients (1, 2). However, the level of the affected area differs in each patient (3). Cases with pseudarthrosis before delivery are rare. In the majority of cases, the sclerotic segment of the tibia loses its integrity during the first two years of life (4–6).
Over the years, numerous options have been developed for the treatment of CPT, with nonunion being the focus of the treatment (7–10). Accordingly, grafting and stimulation techniques have been applied. More recently, biological stimulation applications have become popular (11, 12). Fixation is another crucial factor in the treatment of CPT. The use of plates and intramedullary rods has improved the success rates (13). Currently, however, circular external fixator (CEF) provides better fragment control and ensures simultaneous lengthening (14–18).
The popular technique proposed by Ilizarov was gradually augmented through the use of periosteal grafting (12, 14). This study reviews the clinical and functional results of cases treated by a single surgeon using CEF, periosteal grafting, and intramedullary rodding in the treatment of CPT.
Materials and Methods
The medical and radiological data of 24 patients with CPT, treated by a single surgeon between 1997 and 2017, were retrospectively analyzed. Among these, five cases were treated with the bifocal compression-distraction method using the CEF, one patient was treated with nonvascularized fibular grafting, and a two-stage tibia-fibularization case was excluded from the study. The remaining 17 cases were treated with hamartoma resection, periosteal grafting, CEF application, and an intramedullary rod in the same session as the index operation. All the patients were followed up at least two years after the last surgical intervention. At the last follow-up visit, full-length standing lower extremity X-rays were taken to determine residual deformities and limb length discrapancies (LLD). Ankle range of motion (ROM) was also noted.
Of the 17 patients, 12 were males and 5 were females. Furthermore, 13 patients had concomitant neurofibromatosis. Crawford classification was used to classify the cases (6). Nine cases were classified as Crawford type III, and eight cases were classified as Crawford type IV. All the cases presented with LLD, with a mean value of 2.81 cm (range: 1 to 7 cm). In nine cases, the level of pseudarthrosis was in the distal 1/3 of the tibia (52.9%); in eight patients, the level of pseudarthrosis was in the middle 1/3 of the tibia (47.05%). Only three cases had intact fibula, while the remaining cases had an associated fibular pseudarthrosis. Ten patients had at least one previous surgery, and seven patients were followed up with a brace before being referred to the senior author (Table 1).
Table 1.
Patient data
| Case number | Diagnosis | Crawford Type | LLD (cm) | Pseudarthrosis Level | Fibula Pseudarthrosis |
|---|---|---|---|---|---|
| 1 | NF | 3 | 2 | 1/3 distal | Yes |
| 2 | NF | 3 | 1 | 1/3 distal | Yes |
| 3 | NF | 4 | 4 | 1/3 middle | Yes |
| 4 | NF | 3 | 1 | 1/3 middle | No |
| 5 | idiopathic | 4 | 2 | 1/3 distal | Yes |
| 6 | NF | 4 | 1 | 1/3 middle | No |
| 7 | idiopathic | 4 | 5 | 1/3 distal | Yes |
| 8 | NF | 3 | 4 | 1/3 distal | Yes |
| 9 | idiopathic | 3 | 1 | 1/3 middle | No |
| 10 | NF | 4 | 2 | 1/3 middle | Yes |
| 11 | NF | 3 | 4 | 1/3 middle | Yes |
| 12 | NF | 4 | 5 | 1/3 middle | Yes |
| 13 | NF | 3 | 7 | 1/3 distal | Yes |
| 14 | NF | 4 | 2 | 1/3 distal | Yes |
| 15 | NF | 4 | 2,5 | 1/3 middle | Yes |
| 16 | idiopathic | 3 | 2 | 1/3 distal | Yes |
| 17 | NF | 3 | 1 | 1/3 distal | Yes |
NF: neurofibromatosis; LLD: limb length discrepancy
The mean age of the patients at the time of index operation was 5.6 years (range: 1 to 12.5 years). Bone resections were applied in all cases in the range of 1–3 cm during the surgery. For the resulting bone defects, physeal distraction and/or proximal metaphyseal lengthening was used in three and five cases, respectively. The mean amount of lengthening was 5 cm (range: 3–8 cm) (Table 2).
Table 2.
Operation details
| Case number | Age at surgery (years) | Bone Resection (cm) | Combined Lengthening (cm) | Lengthening Method |
|---|---|---|---|---|
| 1 | 6.4 | 1 | no lengthening | – |
| 2 | 4.5 | 1 | no lengthening | – |
| 3 | 5.4 | 1 | no lengthening | – |
| 4 | 12.5 | 1 | no lengthening | – |
| 5 | 3.3 | 3 | 5 | physeal distraction |
| 6 | 6.3 | 1 | 3 | physeal distraction |
| 7 | 11.2 | 2 | 4 | physeal distraction |
| 8 | 6.2 | 1 | no lengthening | – |
| 9 | 1.3 | 2 | no lengthening | – |
| 10 | 4.2 | 1 | no lengthening | – |
| 11 | 2.7 | 3 | no lengthening | – |
| 12 | 7.8 | 2 | 7 | metaphyseal corticotomy |
| 13 | 5.6 | 1 | no lengthening | – |
| 14 | 0.9 | 2 | 4 | metaphyseal corticotomy |
| 15 | 5.3 | 2 | 6 | metaphyseal corticotomy |
| 16 | 5.4 | 3 | 8 | metaphyseal corticotomy |
| 17 | 7.1 | 2 | 3 | metaphyseal corticotomy |
Surgical technique
The patient was placed in a supine position under general anesthesia on the radiolucent operating table, and the ipsilateral buttock was elevated with a sterile towel. The distal and proximal endpoints of the fibula, joint lines, and planned incisions were marked using a sterile marker under fluoroscopy. An anterior longitudinal incision was used to reach the nonunion site under a sterile tourniquet. The nonunion site, including the hamartoma, was resected (Figure 1). The intramedullary canal of the distal and proximal tibial segments were reamed to a size 0.5 mm larger than that of the inserted Steinman pin (2–3 mm). According to the pseudarthrosis morphology (Crawford type IV), the proximal tibial stump was split into two flaps by performing an incomplete osteotomy using a 10-mm osteotome (Figure 2). A cannulated drill opened the tract for intramedullary rod insertion in the reverse direction of the proximal growth plate of the tibia. A Steinman rod inserted from the heel pad to the proximal tibia growth plate was kept proximal to the ankle joint. Alignment could be maintained through the same intramedullary rodding technique after transverse bone resection and acute docking for selected types (Crawford type III). An incision on the iliac crest of the ipsilateral side was performed after the tourniquet was released and hemostasis was completed. Following the exposure of the iliacus muscle, the fibers of the muscle were dissected and medially elevated to reveal the underlying periosteum. A scalpel was used to draw a rectangular shape in the periosteum. The periosteum was carefully dissected from the cortical bone after a split incision made to the apophysis. The periosteal graft surface was meshed onto a separate plate to increase the surface area of the graft (Figure 3). The inner cortex of the iliac bone and the spongiosa were harvested (Figure 4). The periosteal graft was wrapped around the nonunion site. Furthermore, the edges were sutured with absorbable suture material after a cancellous graft was used to fill the space between the host bone and the periosteal graft (Figure 5). The soft tissue was closed before the CEF application. The preassembled CEF was proximally and distally fixed, with 1.8 mm K-wires. Two Schanz screws of 5 mm diameter were used for additional fixation at the proximal ring level. One Schanz screw was used for each ring for distal and mid-level ring fixations. A percutaneous low-energy osteotomy was performed at the proximal metaphyseal level in cases with simultaneous lengthening. The proximal tibial epiphysis was fixed with at least two olive wires in cases with physeal distraction. The frame should be constructed, properly aligned, and positioned to allow compression at the pseudarthrosis site and distraction at the level of the proximal lengthening osteotomy or physis for bifocal compression-distraction.
Figure 1.

An intraoperative view of the atrophic pseudarthrosis site after circumferential periosteal sleeve excision, with distal (B) and proximal (A) stumps
Figure 2.

The proximal tibial stump is split into two flaps (A) using an osteotome in Crawford type IV cases
Figure 3.

After harvesting a periosteal graft in a rectangular shape, meshing with small separate incisions (white arrow) increases the surface area
Figure 4.

The retraction of the inner cortex of the ilium (white arrow) reveals the cancellous bone. An osteotome is used to harvest the spongiosa of the iliac crest
Figure 5.

The periosteal graft is wrapped at the level of the interpositioned pseudarthrosis area and sutured with absorbable suture material (white arrow) circumferentially around the docking site
After the index operation, the patients were followed up monthly until fixator removal; thereafter, follow-ups were conducted every six months for two years. All patients planned to attend follow-ups until they achieved skeletal maturity. During the follow-up, pain, limping, and ROM of the ankle joint were assessed and recorded. Radiologically, long-standing X-rays as well as anteroposterior and lateral X-rays of the affected leg were utilized to detect any residual deformities and LLD.
A small window in the tibial diaphysis was created to remove the Steinman rod. Forceps were used to firmly hold and remove the rod under floroscopy control from the sole of the foot or tibial tuberosity.
Results
Union was achieved with the index treatment in 15 of the 17 cases (88.2%). The mean treatment time was 7.6 months (range: 4.6–9.7 months). In all the cases, a neutral alignment was provided with intramedullary rodding during surgery; however, in case 7, axial deviation experienced by the patient during the treatment was corrected with a frame modification. Nine patients developed ankle valgus, and cases 5, 6, and 14 of these patients had supramalleolar correction osteotomy during follow-up (Table 3).
Table 3.
Results
| Case Number | LLD* (cm) | External Fixator Time (months) | Healing Time (days) | Patient Total Follow Up (years) | Age at Final Follow Up (years) | Ankle ROM+ | Pain | Limping | Residual Ankle Valgus | Lateral Distal Tibia Angle | Refractures |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.0 | 6 | 251 | 15.7 | 22.2 | DF=0. PF=20 | moderate walking | no | no | 87 | no |
| 2 | 4.0 | 7 | 216 | 12.5 | 17.0 | DF=10. PF=20 | extended walking | yes | yes | 83 | no |
| 3 | 5.0 | 9 | 296 | 12.5 | 17.5 | DF=0. PF=30 | none | yes | yes | 80 | no |
| 4 | 1.0 | 9 | 261 | 8.9 | 21.4 | DF=10. PF=20 | extended walking | yes | no | 89 | Yes (after 7y) |
| 5 | 0.0 | 6 | 190 | 13.0 | 16.4 | no motion | none | no | no | 90 | Yes (after 4y) |
| 6 | 0.0 | 4.5 | 138 | 10.2 | 16.5 | DF=0. PF=5 | none | no | no | 91 | no |
| 7 | 3.0 | 5 | 267 | 2.2 | 13.4 | no motion | none | none | no | 90 | no |
| 8 | 0.0 | 5.5 | 168 | 13.8 | 19.9 | no motion | extended walking | yes | no | 87 | no Yes (after 8.6y) |
| 9 | 3.0 | 8 | 245 | 6.4 | 7.7 | DF=10. PF=20 | none | yes | no | 87 | Yes (after 2y) |
| 10 | 2.0 | 2 | 153 | 11.7 | 15.9 | no motion | extended walking | yes | yes | 79 | no |
| 11 | 7.5 | 5 | no healing | 8.6 | 11.3 | no motion | none | yes | no | 91 | |
| 12 | 0.0 | 8 | 236 | 2.6 | 11.3 | no motion | none | no | no | 88 | no |
| 13 | 8.0 | 4.5 | 175 | 8.5 | 14.1 | DF=10. PF=20 | extended walking | yes | no | 86 | no |
| 14 | 2.0 | 4 | 264 | 6.7 | 7.6 | DF= 5. PF=10 | none | none | no | 89 | no |
| 15 | 0.0 | 7 | no heling | 3.0 | 8.3 | no motion | none | no | yes | 72 | |
| 16 | 3 (o.c.) | 8.5 | 290 | 3.9 | 9.3 | DF=10. PF=20 | none | no | yes | 81 | no |
| 17 | 0.0 | 5.5 | 263 | 4.8 | 11.9 | DF=10. PF=20 | none | no | yes | 80 | Yes (after 4.2y) |
LLD: Limb length discrepancy at last follow up visit; ROM+: Range of motion; DF: Dorsiflexion; PF: Plantar flexion
In cases 11 and 15, the index operations resulted in persistent nonunion, which was treated through free vascularized fibular transfer, using plate and screw fixation. In case 11, the preoperative LLD was 3 cm. Fibular integrity was lost during the treatment despite the preserved alignment of the fibula with intramedullary K-wire. Union was achieved after five months through free vascularized fibula transfer. This procedure was followed-up for 4.9 years without any complications until a final lengthening operation was performed using CEF (Table 4). During the last follow-up, the patient was mobile and functional. In case 15, pseudarthrosis persisted after seven months of external fixator duration. The patient was treated with free vascularized fibula transfer. Future lengthening procedures were planned for the expected LLD for this patient.
Table 4.
Additional surgeries after the index treatment
| Case | Successive Surgeries † | Object | Technique | Interval Between Previous surgery (years) | Complications |
|---|---|---|---|---|---|
| 1 | 1st Surg | LLD + Genu Recurvatum | Ilizarov method + intramedullary rodding | 5.1 | Regenerate Fracture |
| 2nd Surg | Regenerate Fracture | Intramedullary rod revision + casting | 1.6 | Delayed Union | |
| 2 | 1st Surg | LLD + Tibia Vara | Lengthening and Correction with CAF | 1.4 | none |
| 4 | 1st Surg | Profilactic TEN application | Titanium Elastic Nailing | 0.9 | Implant failure + Refracture |
| 2nd Surg | Implant Failure + Refracture | Replication of the Index Treatment with consecutive lengthening | 5.9 | Delayed Regenerate Maturation | |
| 3rd Surg | Regenerate Maturation Delay + Genu Valgum | Acute Deformity Correction + Intramedullary Nailing | 1.3 | none | |
| 5 | 1st Surg | LLD + Oblique Plane Deformity | Ilizarov Method + Revision of intramedullary rodding | 0.9 | none |
| 2nd Surg | Ankle Malorientation | Supramalleolar Osteotomy | 2.6 | none | |
| 3rd Surg | Refracture | Intramedullary rodding + casting | 0.8 | Pseudoarthrosis | |
| 4th Surg | Pseudarthrosis | Replication of the Index Treatment with consecutive lengthening | 3.1 | none | |
| 6 | 1st Surg | Ankle Malorientation + Tibia Vara | Supramalleolar Osteotomy | 2.1 | none |
| 7 | 1st Surg | LLD + Genu Valgum | Frame Transformation for Deformity Correction + Re-corticotomy | 1.1 | none |
| 8 | 1st Surg | LLD + Distal tibia sagittal plane deformiy | Ilizarov Method | 2.9 | Delayed Union |
| 2nd Surg | LLD + Genu Valgum | Distal femur FAN + Proximal Tibia Correction and lengthening with CAF | 3.8 | none | |
| 3rd Surg | Refracture | Osteosyntesis with Ilizarov Method | 1.9 | none | |
| 4rd Surg | Contralateral Ankle Valgus (Donor Site Morbidy) | Contralateral Supramalleolar Osteotomy | 2.9**** | none | |
| 9 | 1st Surg | Refracture + LLD + Oblique Plane Deformity | Ilizarov Method | 1.9 | Axial Deviation, Refracture after 2 y FU |
| 2nd Surg | LLD + Pseudarthrosis | Replication of the Index Treatment with consecutive lengthening | 3.1 | none | |
| 11 | 1st Surg | LLD + Pseudarthrosis | Transformation to unilateral fixator + DBM grafting | 0.5 | No Healing |
| 2nd Surg | LLD + Pseudarthrosis | Vascularized Fibula Transfer | 1.4 | none | |
| 3rd Surg | LLD | Lengthening with Ilizarov Method | 4.9 | none | |
| 14 | 1st Surg | LLD + Ankle Valgus | Ilizarov Method | 2.3 | none |
| 15 | 1st Surg | Pseudarthrosis | Ilizarov Method | 2.0 | No Healing |
| 2nd Surg | Pseudarthrosis + Bone Defect | Vascularized Fibula Transfer | 1.0 | none | |
| 17 | 1st Surg | Refracture + LLD | Replication of the Index Treatment with consecutive lengthening | 4.2 | none |
LLD: limb length discrepancy; ROM: range of motion; DF: Dorsiflexion; PF: plantar flexion; CAF: computer assisted fixator
Donor site morbidity related interval is 12 years 4 months
1st Surg is considered the next surgical intervention after the index treatment
The mean follow-up period for patients in this series was 8.5 years (range: 2.2 to 15.7 years) for all surgeries. The mean age of the patients at the last follow-up visit was 14.2 years (range: 7.6 to 22.1 years). In this series, cases 9, 14, 15, 16, and 17) were skeletally immature at the last follow-up visit. In cases 4, 5, 8, 9, and 17, the index treatment technique was complicated by refracture (Table 3). The refractures were treated with a replication of the index treatment in cases 4, 5, and 17 and with the Ilizarov method (8) in cases 8 and 9 (Table 4). Separate consecutive surgeries were required for the following cases: oblique plane deformity and ankle valgus in case 5; tibia bowing and ankle valgus in case 6; an LLD of 6 cm in case 8; equinovalgus contracture of the ankle in case 14. Recorticotomy and frame modification were applied for axial deviation in cases 7 and 9 (Table 4).
The mean LLD at the last follow-up was 2.1 cm. Six patients reported radiological ankle valgus at the last follow-up. Cases 2, 4, 9, 13, 16, and 17 with ankle ROM recovered, with 10 degrees of dorsiflexion and 20 degrees of plantar flexion. Cases 5, 7, 8, 10, 11, 12, and 15 had stiff ankle joint at the last follow-up. Cases 1, 3, 6, and 14 had limited ankle joint ROM, enabling them to perform painless daily activities (Table 3) (Figure 6–8).
Figure 6. a, b.

A case of a six-year-old boy with congenital pseudarthrosis of the tibia. A demineralized bone matrix and cancellous bone grafting was applied, with plate and screw fixation, through a previous surgery at a different center. Preoperative anteroposterior (a) and lateral (b) X-rays indicate the pseudarthrosis site with intact fibula
Figure 7. a, b.

Postoperative anteroposterior (a) and lateral (b) radiographs of the same patient. The frame was mounted, properly aligned, and positioned with compression at the pseudarthrosis site and proximal lengthening. Proximal metaphyseal osteotomy was used for concomitant lengthening
Figure 8.

Solid union, good alignment, without residual ankle valgus, tibial bowing, and LLD were revealed by the long-standing lower extremity X-ray of the same patient at the three-year follow-up. The rod was maintained in the intramedullary cavity without affecting the ankle and subtalar joints
Discussion
External fixator application for the treatment of CPT has been widely used with technical modifications such as periosteal grafting, intramedullary rodding, or electrical stimulation (8, 12, 14–17). Several studies have suggested the use of bone morphogenetic proteins (BMPs) in surgical techniques for healing. However, there exists limited evidence concerning the effectiveness of BMPs (11, 19, 22, 35). Furthermore, multiagent therapy using BMP and zolendronic acid was concluded to be superior (20, 21, 34). In our series, we avoided the use of BMP or zolendronic acid.
Intramedullary rodding was the primary choice of treatment before the popularization of external fixation (23–25). Mechanical factors were indicated as the primary reasons for high complication rates during treatment. Maintaining the alignment is crucial as this creates compression forces leading to union. Coleman popularized a procedure using autogenous bone grafting (23, 26). In his series, Anderson suggested maintaining the intramedullary rod until skeletal growth. Schonecker reported union rates of 85.7%, with refracture rates of 66.6%, when reporting the long-term results of intramedullary rod treatments for CPT. Schonecker et al. suggested liberating the subtalar joint after five years and liberating the tibiotalar joint after ten years to ensure that the rod at the ankle joint was as short as possible (13, 23). We used intramedullary rodding with CEF as internal bracing as long as possible. However, consecutive surgeries were generally required to replace or remove Steinman pins due to further corrections and lengthening procedures in selected patients.
The CPT treatment aims at obtaining and maintaining union. Boero et al. reported an 81% union rate and a 23.5% refracture rate in 21 cases treated using CEF with various device assembly options. They concluded that the short-term compression of stumps after resection until biologically and mechanically viable bone growth is the primary factor for better results (3). Paley and Kocaoglu published their treatment results for 20 cases treated with a CEF combined with periosteal grafting and intramedullary rodding in a multicenter study and indicated 100% union and 40% refracture rates. More than half of the patients were aged below 4 years in this series and were skeletally immature during the last follow-up, which explains the lower refracture rates (14). Choi et al. reported eight cases of atrophic-type pseudarthrosis using a “4-in-1 osteosynthesis,” with a mean age of 6.3 years. Using CEF in selected patients, they reported a 100% union rate, with no refractures during a mean follow-up period of 3.5 years (range: 2.7–10.2 years). Depending on the fibular status, a complete union between a broader cross-sectional area at the pseudarthrosis site was suggested, without losing the lateral support of the ankle caused by fibular shortening (15). In our series, broader cross-sectional areas were encountered in two patients after unintended tibio-fibular cross-union. Song reported 15 patients treated with CEF and intramedullary rod augmentation without periosteal grafting. The union rate was 40% for the initial index surgery and 93% after consecutive surgeries in patients with no primary healing. The refracture rate was 6.6% during a 4.2-year follow-up period (16). In this series, we reported 88.2% union and 33.3% refracture rates during an 8.5-year follow-up period, highlighting the importance of periosteal grafting. In the literature, success probability (union rate×[1−mean refracture rate]) is 40% in intramedullary rodding, 57% in the Ilizarov method, 58% in the Ilizarov method combined with intramedullary rodding, 58% in vascularzed fibula grafting, and 50% in all published series. According to this definition, we reported a success probability of 58.7% (34).
We excluded two series by Inan et al. and Cho et al. due to the heterogeneous external fixation treatment protocols used in these series (29, 30). Our series has the longest follow-up duration. In addition, the youngest patient was aged 11 months despite the controversy within the field regarding the appropriate age for the initial treatment. The multicenter study reported by the European Paediatric Orthopaedic Society suggested operating only on children aged over 3 years (27). In addition, Boero et al. reported better results for patients aged above 5 years when performing external fixation treatments (3). With regard to the refracture, union, and complication rates, Liu et al. reported no significant differences between patients who received operations before and after 3 years of age; however, LLDs differed between the two groups (28). In this series, we had two different groups with regard to the age of the index operation. The first group comprised patients who received initial operations elsewhere and were referred to us with complications from treatment, such as nonunion and refracture. These patients were treated using the periosteal graft method without consideration of age. The second group comprised patients first diagnosed by the senior author and followed-up by bracing. If they experienced any fractures during bracing, they were operated; otherwise, we preferred to wait until 4 years of age.
One of the main concerns during the follow-up of the treatment of CPT was residual valgus deformity of the ankle. Because of this, fibular surgeries were recommended, and longer refracture-free survival rates were expected (30, 31, 33, 34). Thabet et al. reported 35% ankle valgus in the 4.3-year follow-up period and suggested screw or plate hemiephiphysiodesis (14). Choi et al. defined a classification system according to the fibular morphology and suggested a 4-in-1 technique for patients with a specific type of fibular patology (32). In our series, nine patients developed ankle valgus deformity during follow-up. Supramalleolar osteotomy was the preferred choice of treatment for symptomatic three patients. Remaining six cases, who displayed subtalar compensation in ankle valgus, are potential candidates for future corrections; however, they have not reported any clinical symptoms such as limping or pain.
The primary difficulty in the treatment of CPT is the achievement of the union. CEF with periosteal grafting is a superior method; this method provides a healthy biologic healing milieu and achieves union by correcting the mechanical problems. The combination of periosteal and cancellous bone grafts with intramedullary rods and external fixators addresses all issues that complicate union in CPT treatment.
Footnotes
Ethics Committee Approval: Ethics committee approval was received for this study from the Ethics Committee of İstanbul University, İstanbul School of Medicine (23.05.2018 - 67218/14).
Informed Consent: Written informed consent was obtained from patients and/or patients’ family members who participated in this study.
Author Contributions: Concept - M.K., LE.; Design - M.K., L.E.; Supervision - M.K.; Resources - M.K., L.E.; Materials - M.K., L.E.; Data Collection and/or Processing - M.C., F.E.B.; Analysis and/or Interpretation - M.K, L.E.; Literature Search - M.C., F.E.B.; Writing Manuscript - M.C.; Critical Review - M.K., L.E., F.E.B.
Conflict of Interest: The authors have no conflicts of interest to declare.
Financial Disclosure: The authors declared that this study has received no financial support.
References
- 1.Campanacci M, Nicoll E, Pagella P. The differential diagnosis of congenital pseudarthrosis of the tibia. Int Orthop. 1981;4:283–8. doi: 10.1097/01241398-198112000-00042. [DOI] [PubMed] [Google Scholar]
- 2.Brown AG, Osebold WR, Ponseti IV. Congenital pseudarthrosis of long bones. A clinical radiographic, histologic and ultrastructural study. Clin Orthop. 1977;128:228. doi: 10.1097/00003086-197710000-00034. [DOI] [PubMed] [Google Scholar]
- 3.Boero S, Catagni M, Donzelli O, Facchini R, Frediani PV. Congenital pseudarthrosis of the tibia associated with neurofibromatosis-1: treatment with Ilizarov’s device. J Pediatr Orthop. 1997;17:675–84. doi: 10.1097/01241398-199709000-00019. [DOI] [PubMed] [Google Scholar]
- 4.Wientroub S, Grill F. Congenital pseudarthrosis of the tibia: Part 1. European Pediatric Orthopaedic Society multicenter study of congenital pseudoarthrosis. J Pediatr Orthop. 2000;9:1–2. doi: 10.1097/01202412-200001000-00001. [DOI] [PubMed] [Google Scholar]
- 5.Boyd HB. Pathology and natural history of congenital pseudarthrosis of the tibia. Clin Orthop Rel Res. 1982;166:5–13. doi: 10.1097/00003086-198206000-00003. [DOI] [PubMed] [Google Scholar]
- 6.Crawford AH, Schorry EK. Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg. 1999;7:217–30. doi: 10.5435/00124635-199907000-00002. [DOI] [PubMed] [Google Scholar]
- 7.Charnley J. Congenital pseudarthrosis of the tibia treated by the intramedullary nail. J Bone Joint Surg. 1956;38:283–90. doi: 10.2106/00004623-195638020-00004. [DOI] [PubMed] [Google Scholar]
- 8.Paley D, Catagni M, Argnani F, Jean P, Deborah B, Peter A. Treatment of congenital pseudoartrosis of the tibia using the Ilizarov Technique. Clin Orthop Relat Res. 1992;280:81–93. doi: 10.1097/00003086-199207000-00011. [DOI] [PubMed] [Google Scholar]
- 9.Weiland A, Weiss A-PC, Moore JR, Tolo VT. Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg. 1990;72:654–62. doi: 10.2106/00004623-199072050-00003. [DOI] [PubMed] [Google Scholar]
- 10.Minami A, Kato H, Suenaga N, Iwasaki N. Telescoping vascularized fibular graft: A new method. J Reconstr Microsurg. 2003;19:11–5. doi: 10.1055/s-2003-37185. [DOI] [PubMed] [Google Scholar]
- 11.Kesireddy N, Kheireldin RK, Lu A, Cooper J, Liu J, Ebraheim NA. Current treatment of congenital pseudarthrosis of the tibia: a systematic review and meta-analysis. J Pediatr Orthop B. 2018;27:541–50. doi: 10.1097/BPB.0000000000000524. [DOI] [PubMed] [Google Scholar]
- 12.Paley D. Congenital pseudarthrosis of the tibia: Combined pharmacologic and surgical treatment using biphosphonate ıntravenous ınfusion and bone morphogenic protein with periosteal and cancellous autogenous bone grafting, tibio-fibular cross union, ıntramedullary rodding and external fixation. Bone Grafting: InTech; 2012. pp. 91–106. [DOI] [Google Scholar]
- 13.Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg. 2004;86:1186–97. doi: 10.2106/00004623-200406000-00010. [DOI] [PubMed] [Google Scholar]
- 14.Thabet AM, Paley D, Kocaoglu M, Eralp L, Herzenberg JE, Ergin ON. Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report. Clin Orthop Relat Res. 2008;466:2981–94. doi: 10.1007/s11999-008-0556-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Choi IH, Lee SJ, Moon HJ, et al. “4-in-1 osteosynthesis” for atrophic-type congenital pseudarthrosis of the tibia. J Pediatr Orthop. 2011;31:697–704. doi: 10.1097/BPO.0b013e318221ebce. [DOI] [PubMed] [Google Scholar]
- 16.Agashe MV, Song SH, Refai MA, Song HR. Congenital pseudarthrosis of the tibia treated with a combination of Ilizarov’s technique and intramedullary rodding. Acta Orthop. 2012;83:515–22. doi: 10.3109/17453674.2012.736170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhu GH, Mei HB, He RG, et al. Combination of intramedullary rod, wrapping bone grafting and Ilizarov’s fixator for the treatment of Crawford type IV congenital pseudarthrosis of the tibia: mid-term follow-up of 56 cases. BMC Musculoskelet Disord. 2016;17:443. doi: 10.1186/s12891-016-1295-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yan A, Mei H, Liu K, et al. Curative effects of combination therapy with 4-in-1 osteosynthesis and surgical techniques against congenital pseudarthrosis of the tibia in children. Int J Clin Exp Med. 2018;11:5997–6008. [Google Scholar]
- 19.Richards BS, Oetgen ME, Johnston CE. The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series. J Bone Joint Surg. 2010;92:177–85. doi: 10.2106/JBJS.H.01667. [DOI] [PubMed] [Google Scholar]
- 20.Schindeler A, Ramachandran M, Godfrey C, et al. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice. J Orthop Res. 2008;26:65–74. doi: 10.1002/jor.20481. [DOI] [PubMed] [Google Scholar]
- 21.Fabeck L, Ghafil D, Gerroudj M, Baillon R, Delincé P. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Br. 2006;88:116–8. doi: 10.1302/0301-620X.88B1.16619. [DOI] [PubMed] [Google Scholar]
- 22.Shah H, Joseph B, Nair BVS, et al. What factors influence union and refracture of congenital pseudarthrosis of the tibia? A multicenter long-term study. J Pediatr Orthop. 2018;38:e332–e7. doi: 10.1097/BPO.0000000000001172. [DOI] [PubMed] [Google Scholar]
- 23.Anderson DJ, Schoenecker PL, Sheridan JJ, Rich MM. Use of an ıntramedullary rod treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg. 1992;74:161–8. doi: 10.2106/00004623-199274020-00002. [DOI] [PubMed] [Google Scholar]
- 24.Baker JK, Cain T, Tullos H. Intramedullary fixation for congenital pseudarthrosis of the tibia. J Bone Joint Surg. 1992;74:169–78. doi: 10.2106/00004623-199274020-00003. [DOI] [PubMed] [Google Scholar]
- 25.Fern E, Stockley I, Bell M. Extending intramedullary rods in congenital pseudarthrosis of the tibia. J Bone Joint Surg. 1990;72:1073–5. doi: 10.1302/0301-620X.72B6.2246292. [DOI] [PubMed] [Google Scholar]
- 26.Umber JS, Moss SW, Coleman SS. Surgical treatment of congenital pseudarthrosis of the tibia. Clin Orthop Rel Res. 1982;166:28–33. doi: 10.1097/00003086-198206000-00006. [DOI] [PubMed] [Google Scholar]
- 27.Grill F, Bollini G, Dungl P, et al. Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS) J Pediatr Orthop B. 2000;9:75–89. doi: 10.1097/01202412-200004000-00002. [DOI] [PubMed] [Google Scholar]
- 28.Liu Y, Mei H, Zhu G, et al. Congenital pseudarthrosis of the tibia in children: should we defer surgery until 3 years old? J Pediatr Orthop B. 2018;27:17–25. doi: 10.1097/BPB.0000000000000468. [DOI] [PubMed] [Google Scholar]
- 29.Inan M, El Rassi G, Riddle EC, Kumar SJ. Residual deformities following successful initial bone union in congenital pseudoarthrosis of the tibia. J Pediatr Orthop. 2006;26:393–9. doi: 10.1097/01.bpo.0000217716.64986.f0. [DOI] [PubMed] [Google Scholar]
- 30.Cho TJ, Choi IH, Lee SM, et al. Refracture after Ilizarov osteosynthesis in atrophic-type congenital pseudarthrosis of the tibia. J Bone Joint Surg. 2008;90:488–93. doi: 10.1302/0301-620X.90B4.20153. [DOI] [PubMed] [Google Scholar]
- 31.Johnston CE. Congenital pseudarthrosis of the tibia. Results of technical variations in the Charnley-Willams Procedure. J Bone Joint Surg. 2002;84:1799–810. doi: 10.2106/00004623-200210000-00010. [DOI] [PubMed] [Google Scholar]
- 32.Choi IH, Cho TJ, Moon HJ. Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique. Clin Orthop Surg. 2011;3:1–8. doi: 10.4055/cios.2011.3.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Joseph B, Mathew G. Management of congenital pseudarthrosis of the tibia by excision of the pseudarthrosis, onlay grafting, and intramedullary nailing. J Pediatr Orthop Part B. 2000;9:16–23. doi: 10.1097/01202412-200001000-00004. [DOI] [PubMed] [Google Scholar]
- 34.Paley D. Congenital pseudarthrosis of the tibia: biological and biomechanical considerations to achieve union and prevent refracture. J Child Orthop. 2019;13:120–33. doi: 10.1302/1863-2548.13.180147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Birke O, Schindeler A, Ramachandran M, et al. Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. J Child Orthop. 2010;4:507–17. doi: 10.1007/s11832-010-0293-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
